Precise Bio announces launch of ophthalmology-focused unit

The regenerative medicine company has announced the launch of a business unit to focus on ophthalmology for the development of near-term 3D bioprinted ophthalmologic solutions. Precise Bio (NC, USA), a regenerative medicine company working towards advancing bioprinted tissues and organs for patient use, has announced the launch of an ophthalmology-dedicated business unit. The announcement was made in conjunction with various other events hosted by Precise Bio as well as other collaborators at the American Academy of Ophthalmology (AAO), which took place from October 27–30, 2018 in Chicago (IL, USA).  “There has been great excitement among physicians and commercial organizations about...